OPTH

Optimi Health

• TipRanks·3d ago

  Optimi Health Adds Veteran Finance Executive Melanie Pump to Board

• TipRanks·09/24 14:30

  Psychedelic: Optimi completes psilocybin production for Phase 2 trial

• TipRanks·09/23 15:09

  Optimi Health Aligns Clinical and Commercial Psilocybin Supply With New cGMP Batch

• Benzinga·09/23 13:03

  Optimi Health Completes Production Batch Of 5mg Naturally Derived Psilocybin Capsules, Manufactured End To End At cGMP Facility In Princeton, British Columbia

• TipRanks·09/17 13:55

  Psychedelic: Definium’s LSD-based drug meets endpoints in GAD study

• Benzinga·09/17 08:31

  Elon Musk Once Said Psychedelics Could Help PTSD — Now FDA Holds Hearing as Optimi Health Advances MDMA Trial

• TipRanks·09/16 15:38

  Optimi Health to Launch Phase 3 MDMA Trial for PTSD in Veterans and Frontline Workers

• Benzinga·09/16 12:27

  Optimi Health Plans To Initiate A Phase 3 Clinical Trial Evaluating MDMA-Assisted Therapy For PTSD Authorized By Health Canada; Trial Is Expected To Begin In 2027

• TipRanks·09/10 14:50

  Psychedelic: Optimi to initiate Phase 2 trial of psilocybin-assisted therapy

• TipRanks·09/10 14:25

  Optimi Health to initiate Phase 2 trial of psilocybin-assisted therapy for MDD

• NASDAQ·09/10 13:08

  Optimi Health To Initiate Phase 2 Psilocybin Trial For Major Depression

• Benzinga·09/10 12:51

  Optimi Health Plans To Initiate Multisite Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy For Individuals With Major Depressive Disorder In H1 2027, With Dosing Expected To Be Complete By 2027 End

• Seeking Alpha·08/17 13:52

  Optimi Health Corp. GAAP EPS of -$0.56, revenue of $239.7M

• TipRanks·08/16 12:38

  Optimi Health establishes discretionary equity facility

• TipRanks·08/14 21:40

  Optimi Health Sets Up US$100 Million Equity Line for Psychedelic Drug Expansion